AzTrials
AzTrials

StressACTNCT03826732

Acceptance and Commitment Therapy (ACT) Self-help to Reduce Stress

A study testing Guided self-help based on ACT in people with Stress, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The efficacy of guided self-help based on acceptance and commitment therapy (ACT) to reduce subjective sense of stress will be investigated in a randomised controlled trial with two condition: 1) ACT-based self-help, and 2) Wait-list control. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Guided self-help based on ACT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
133 participants
Where
1 siteSweden
Study dates
25 Jan 2019to 29 May 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age above 18
  • DASS score above 14
  • PHQ-9 below 9

Who cannot join

  • Any indications of suicidality
  • Any indication of other psychiatric disorder in need of immediate attention/treatment
  • Concurrent psychotherapy or other treatments for stress
  • Previous work with the self-help book

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Karolinska Institutet

    Solna, 17177

Other trials in Sweden

About this study

Official title: Guided Self-help Based on Acceptance and Commitment Therapy to Reduce Perceived Stress

The efficacy of guided self-help based on acceptance and commitment therapy (ACT) to reduce subjective sense of stress will be investigated in a randomised controlled trial with two condition: 1) ACT-based self-help, and 2) Wait-list control. The outcome at the end of the treatment (week 10) and 6-month follow-up will be assessed. The wail-list condition will be offered ACT-based self-help after the post-assessment.

Read the detailed description

The efficacy of guided self-help based on acceptance and commitment therapy (ACT) to reduce subjective sense of stress will be investigated in a randomised controlled trial with two condition: 1) ACT-based self-help, and 2) Wait-list control. The outcome at the end of the treatment and 6-month follow-up will be assessed. The wail-list condition will be offered ACT-based self-help after 10 weeks (i.e. when the post-assessment is completed). Inclusion criteria are: Adults with a score above 14 on the stress sub scale of the Depression, Anxiety, Stress Scale (DASS) at screening, a score below 10 on the Patient Health Questionnaire (PHQ-9), no indication of suicidality on the PHQ-9, and no ongoing psychotherapeutic interventions, and no previous work with the self-help manual that has been published as a self-help book.

A total of 140 participants will be recruited and randomised, using services on www.random.org. Informed consent will be obtained from all the participants ahead of screening. Participants will be asked to respond to the following questionnaires at pre-, post and follow-up assessments: Perceived Stress Scale-14 (PSS-14), General Anxiety Disorder-7 (GAD-7), Shirom Melamed Burnout Measure (SMBM), and Brunnsviken Brief Quality of Life Inventory (BBQ). Initially, they will also be asked to respond to the credibility/Expectancy Questionnaire (CEQ).

At the end of the intervention (week 10), participants will also be asked to respond to the Client Satisfaction Questionnaire (CSQ), and the Negative Effects Questionnaire (NEQ).

The following two scales will be used to study mediators: Acceptance and Action Questionnaire-2 (AAQ-2), and Attention Awareness Scale (MAAS), assess at pre-treatment, as well as at third and fifth week of treatment, at post-assessment (10 weeks later), and at the 6 months follow-up. A number of moderators, including demographics, will also be investigated.

Conditions
Stress
Being tested
Guided self-help based on ACT

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Guided self-help based on ACTBehavioural

    ACT-based self-help book and regular support by trained facilitators

Study groups in NCT03826732
Study groupRoleWhat they receive
Guided self-help based on ACTExperimentalParticipants follow a self-help program and receive weekly support by trained facilitators
Receives: Behavioral: Guided self-help based on ACT
Wait-list controlNo interventionParticipants are informed that they will receive the intervention after the 6-month follow-up assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived Stress Scale-14 (PSS-14)

    The PSS-14 is measure of stress. Its total score ranges from 0-56. Lower values represent a better outcome.

    Measured: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up

Secondary outcomes (8)
  1. Patient Health Questionnaire-9 (PHQ-9)

    The PHQ-9 provides a measure of depressive symptomatology. It ranges from 0-27. Lower values represent a better outcome

    Measured: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up

  2. General Anxiety Disorder-7 (GAD-7)

    The GAD-7 is used to measure anxiety. It ranges from 0-21. Lower values represent a better outcome.

    Measured: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up

  3. Brunnsviken Brief Quality of Life Inventory (BBQ)

    The BBQ is a Swedish measure of quality of life. It ranges from 0-96. Higher values represent a better outcome.

    Measured: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up

  4. Shirom Melamed Burnout Measure (SMBM)

    The SMBM provides a measure of burn-out. It has three sub-scales: 1) physical exhaustion, 2) cognitive fatigue, and 3) emotional exhaustion. The subscales are combined to compute a total score by summing the mean of the subscales. Scale ranges from 3-15. Higher values represent a better outcome.

    Measured: Pre- and post-assessment (10 weeks later) as well as 6 months follow-up

  5. Acceptance and Action Questionnaire-2 (AAQ-2)

    To Measure psychological flexibility (mediator of change). It ranges from 7-49. Lower values represent a better outcome.

    Measured: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up

  6. Mindful Attention Awareness Scale (MAAS)

    To measure mindfulness (potential mediator of change). The score is computed by the mean of the 15 items and the resulting scale ranges from 1-6. Higher values represent a better outcome.

    Measured: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up

  7. Client Satisfaction Questionnaire (CSQ)

    To measure satisfaction and dissatisfaction with the intervention. It ranges from 8-32. Higher values indicate higher satisfaction.

    Measured: Post-assessment, and 6 month follow-up

  8. Negative Effects Questionnaire (NEQ)

    To identify iatrogenic events. It ranges from 0-128. Lower values represent a better outcome (i.e. fewer negative effects from the intervention).

    Measured: Post-assessment, and 6 month follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2019
  2. Study start25 Jan 2019
  3. Primary completion1 Sep 2019
  4. Study completion29 May 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomization into active treatment versus a wait-list control group
Masking
None (open label)
Enrolment
133 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03826732
Sponsor's protocol ID
AGFLDE
Acronym
ACT
Status last verified
Sep 2020
First submitted
24 Jan 2019
Last updated
14 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Unidentified data will be made available to other researchers upon request.

Questions about this trial

What is this clinical trial studying?

A study testing Guided self-help based on ACT in people with Stress, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived Stress Scale-14 (PSS-14) (time frame: Pre-assessment, week 3 and 5 of intervention, post-assessment (week10), and 6 months follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
ACT Clinical Trial NCT03826732 | AzTrials